Report
Valens Research

KMB - Embedded Expectations Analysis - 2021 03 16

Kimberly-Clark Corporation (KMB:USA) currently trades near recent averages relative to UAFRS-based (Uniform) earnings, with a 23.7x Uniform P/E. At these levels, the market is pricing in expectations for Uniform ROA to remain stable, but management may have concerns about their personal care business, tissue demand, and their online channel market share

Specifically, management may lack confidence in their ability to further gain market share for Kleenex and across online channels, sustain strong momentum for their personal care business, and improve the efficiency of their advertising and supply chain through recent investments. Furthermore, they may have concerns about the sustainability of tissue demand, consistent declines in birth rates across markets, and the sustainability of consumer stockpiling behavior. Finally, they may lack confidence in their ability to sustain volume growth in Africa, and they may have concerns about the continued impact of the pandemic on their business
Underlying
Kimberly-Clark Corporation

Kimberly-Clark is principally engaged in the manufacturing and marketing of a range of products primarily made from natural or synthetic fibers using technologies in fibers, nonwovens and absorbency. The company is organized into three operating segments: Personal Care, which provides solutions and products such as disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, and other related products; Consumer Tissue, which provides facial and bathroom tissue, paper towels, napkins and related products; and K-C Professional, which provides a range of solutions and supporting products such as wipers, tissue, towels, apparel, soaps and sanitizers.

Provider
Valens Research
Valens Research

In 2009, just as the dust was settling from the last major equity and credit market crises, we launched a boutique research firm with the intention of breaking Wall Street’s biases and broken incentives:

  • GAAP and IFRS have failed to provide rules for reliable financial statement reporting
  • Stock analyst recommendations are not grounded in disciplined financial analysis
  • Credit agencies have been set up to grossly fail in their responsibilities to investors and the public markets
  • Utter lack of willingness of major research firms to employ the the most advanced forensic analysis available

We sought to provide investors and company analysts with a source of information that changed all that.
Many years later, our business model remains because little has changed on Wall Street.

  • Corporate credit ratings remain years behind the fundamental underpinnings of company performance
  • Stock analysts continue to make recommendations with deeply inherent biases
  • Research firms have failed to break down the walls between credit, equity, and macroeconomic research
  • The governing accounting bodies have created more leeway for mis-estimates and mis-classifications as financials have become unwieldy and overwhelming

The integrity of Valens Research is founded in our disciplined processes and analytics. No “star” analysts. No corporate advisory relationships. No-nonsense opinions and recommendations.

Analysts
Valens Research

Other Reports on these Companies
Other Reports from Valens Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch